ArticleHead & neck2021
The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors.
Article in Head & neck, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 4 syntheses or guidelines pooled it, 38 citations in OpenAlex.
- Assessing Financial Toxicity in Cancer: A Global Systematic Review and Meta-Analysis Using an Asset Framework.Cancer medicine · 2026Pooled it
- Measuring financial toxicity in head and neck cancer: a systematic review.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2024Pooled it
- Describing financial toxicity among cancer patients in different income countries: a systematic review and meta-analysis.Frontiers in public health · 2023Pooled it
- Interventions for head and neck cancer survivors: Systematic review.Head & neck · 2022Pooled it
- Review
- Development and validation of the subjective financial distress scale for cancer patients.BMC psychology · 2026Article
- Socioeconomic Impact, Equity, and Sustainability in Head and Neck Cancer Surgery: A Structured Narrative Review.Epidemiologia (Basel, Switzerland) · 2026Review
- Financial Toxicity in Selected Head and Neck Cancers: A Scoping Review of Measurement, Burden, and Outcomes.Cancers · 2026Review
- Clinical and social determinants of sustained head and neck cancer survivorship clinic attendance.Journal of cancer survivorship : research and practice · 2026Article
- Financial Toxicity in ESKD.Kidney360 · 2025Article
- Clinical and social determinants of survivorship clinic attendance in head and neck cancer.Journal of cancer survivorship : research and practice · 2025Article
- Social Needs in Cancer Survivors: A Scoping Review and Future Directions.Current oncology reports · 2025Article
- Review
- Financial toxicity and its influencing factors in young and middle-aged cancer patients: a latent profile analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- The impact of financial burden on quality of life among German head and neck cancer survivors.BMC cancer · 2025Article
- Uncovering Care Challenges for Head and Neck Cancer Patients and Caregivers in the United States: A Scoping Review.Cureus · 2025Review
- Financial toxicity-related factors in patients with nasopharyngeal carfcinoma: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Article
- Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer.Current oncology (Toronto, Ont.) · 2023Article
- Financial toxicity among head and neck cancer patients and their caregivers: A cross-sectional pilot study.Laryngoscope investigative otolaryngology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundLittle is documented regarding objective financial metrics and their impact on subjective financial toxicity in head and neck cancer (HNC) survivors.
methodsIn a cross-sectional analysis, 71 survivors with available claims data for HNC-specific out-of-pocket expenses (OOPE) completed a survey including patient-reported, subjective financial toxicity outcome tools: the Comprehensive Score for financial Toxicity (COST) and the Financial Distress Questionnaire (FDQ).
resultsWorse COST scores were significantly associated with lower earnings at survey administration (coefficient = 3.79; 95% CI 2.63-4.95; p < 0.001); loss of earnings after diagnosis (coefficient = 6.03; 95% CI 0.53-11.52; p = 0.032); and greater annual OOPE as a proportion of earnings [log10(Annual OOPE:Earnings at survey): coefficient = -5.66; 95% CI -10.28 to -1.04; p = 0.017]. Similar results were found with FDQ.
conclusionFinancial toxicity is associated with particular socioeconomic characteristics which, if understood, would assist the development of pre-treatment screening tools to detect at-risk individuals and intervene early in the HNC cancer survivorship trajectory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.